PANACEABIO.BOPANACEABIO.BOBSE

Revenue (LTM)

$5.6B

+1.3% YoY

Net Income (LTM)

$-84M

-613.6% YoY

Free Cash Flow

$-777M

Revenue CAGR (5Y)

+0.8%

Marginsdeclining

FCF($0.8B)

Unprofitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	6,176	6,592↑6.7%	4,569↓30.7%	5,519↑20.8%	5,591↑1.3%
Gross Profit	4,130	3,416↓17.3%	1,782↓47.8%	447↓74.9%	3,596↑705.2%
Operating Income	328	-518↓258.0%	-1,057↓103.9%	-138↑86.9%	-607↓339.7%
Net Income	-1,477	10,783↑830.1%	-332↓103.1%	-12↑96.5%	-84↓613.6%
EBITDA	865	16,740↑1834.8%	564↓96.6%	415↓26.3%	307↓26.0%
EPS Diluted	-24.11	176.05↑830.2%	-5.43↓103.1%	-0.19↑96.5%	-1.37↓621.1%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	521	504↓3.3%	399↓20.9%	472↑18.4%	821↑74.1%
Total Current Assets	5,110	9,906↑93.9%	5,683↓42.6%	4,852↓14.6%	5,452↑12.4%
Total Assets	11,775	17,589↑49.4%	12,712↓27.7%	12,407↓2.4%	12,898↑4.0%
Total Current Liabilities	4,491	7,764↑72.9%	3,318↓57.3%	3,088↓6.9%	3,670↑18.8%
Total Liabilities	14,092	8,852↓37.2%	4,311↓51.3%	4,024↓6.6%	4,591↑14.1%
Total Equity	-2,287	8,766↑483.3%	8,436↓3.8%	8,420↓0.2%	8,348↓0.9%
Total Debt	8,195	342↓95.8%	202↓40.8%	210↑3.8%	222↑5.8%
Net Debt	7,674	-162↓102.1%	-196↓21.2%	-262↓33.3%	-599↓128.9%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	1,067	-1,084↓201.7%	-4,225↓289.5%	-1↑100.0%	-274↓27270.0%
Capital Expenditure	-218	-125↑42.5%	-409↓227.3%	-777↓89.8%	-503↑35.3%
Free Cash Flow	850	-1,210↓242.3%	-4,634↓283.1%	-778↑83.2%	-777↑0.2%
Stock-Based Comp	0	0	0	0	0
Net Change in Cash	119	-17↓114.6%	-105↓507.2%	73↑169.7%	350↑377.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance